The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Gulf War and Health: Volume 1. Depleted Uranium, Sarin, Pyridostigmine Bromide, Vaccines
CD-Rats. Available from the National Technical Information Service. NTIS/ADA248 617/3.
Bucci TJ, Parker RM, Gosnell PA. 1993. Toxicity Studies on Agents GB and GD (Phase 2): Delayed Neuropathy Study of Sarin, Type II, in SPF White Leghorn Chickens. Available from the National Technical Information Service. NTIS/AD-A257357.
Burchfiel JL, Duffy FH. 1982. Organophosphate neurotoxicity: Chronic effects of sarin on the electroencephalogram of monkey and man. Neurobehav Toxicol Teratol 4(6):767–778.
Burchfiel JL, Duffy FH, Van Sim M. 1976. Persistent effects of sarin and dieldrin upon the primate electroencephalogram. Toxicol Appl Pharmacol 35(2):365–379.
CDC (Centers for Disease Control and Prevention). 1999. Background Document on Gulf War-Related Research for the Health Impact of Chemical Exposures During the Gulf War: A Research Planning Conference. Atlanta, GA: CDC.
Chebabo SR, Santos MD, Albuquerque EX. 1999. The organophosphate sarin, at low concentrations, inhibits the evoked release of GABA in rat hippocampal slices. Neurotoxicology 20(6):871–882.
CIA–DoD (Central Intelligence Agency and Department of Defense). 1997. Modeling the Chemical Warfare Agent Release at the Khamisiyah Pit. Washington, DC: CIA– DoD.
Clement JG. 1991. Variability of sarin-induced hypothermia in mice: Investigation into incidence and mechanism. Biochem Pharmacol 42(6):1316–1318.
Clement JG. 1992. Efficacy of various oximes against GF (cyclohexyl methylphosphonofluoridate) poisoning in mice. Arch Toxicol 66(2):143–144.
Committee on Veterans’ Affairs, U.S. Senate. 1998. Report of the Special Investigation Unit on Gulf War Illnesses. 105th Congress, 2nd session. Washington, DC: U.S. Government Printing Office. S.PRT 105-39.
Crowell JA, Parker RM, Bucci TJ, Dacre JC. 1989. Neuropathy target esterase in hens after sarin and soman. J Biochem Toxicol 4(1):15–20.
Dasheiff RM, Einberg E, Grenell RG. 1977. Sarin and adrenergic–cholinergic interaction in rat brain. Exp Neurol 57(2):549–560.
Davies DR, Holland P, Rumens MJ. 1960. The relationship between the chemical structure and neurotoxicity of alkyl organophosphorus compounds. Brit J Pharmacol 15:271–278.
Davies DR, Holland P. 1972. Effect of oximes and atropine upon the development of delayed neurotoxic signs in chickens following poisoning by DFP and sarin. Biochem Pharmacol 21(23):3145–3151.
Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE. 1996. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nature Genetics 14(3):334–336.
De Bleecker JL, De Reuck JL, Willems JL. 1992. Neurological aspects of organophosphate poisoning. Clin Neurol Neurosurg 94:93–103.
D’Mello GD, Duffy EA. 1985. The acute toxicity of sarin in marmosets (Callithrix jacchus): A behavioral analysis. Fundam Appl Toxicol 5(6 Pt 2):S169–S174.
Duffy FH, Burchfiel JL, Bartels PH, Gaon M, Sim VM. 1979. Long-term effects of an organophosphate upon the human electroencephalogram. Toxicol Appl Pharmacol 47(1):161–176.
Fernando JC, Hoskins BH, Ho IK. 1984. A striatal serotonergic involvement in the behavioural effects of anticholinesterase organophosphates. Eur J Pharmacol 98(1): 129–132.